WJ-39
Catalog No.
BA3271
WJ-39 is an aldose reductase inhibitor with oral activity.
Featured Products
WJ-39 is an orally active aldose reductase inhibitor.WJ-39 ameliorates tubular injury in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitochondrial autophagy and attenuating apoptosis.
Physical Appearance | A solid |
Storage | 4°C, protect from light |
M.Wt | 430.32 |
Cas No. | 3009908-95-3 |
Formula | C19H14Cl2KNO4 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |